Panczel, I.; Acs, M.; Herold, M.; Madar-Dank, V.; Piso, P.; Schlitt, H.J.; Dank, M.; Szasz, A.M.; Herold, Z. Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2024, 25, 7495. https://doi.org/10.3390/ijms25137495

AMA Style

Panczel I, Acs M, Herold M, Madar-Dank V, Piso P, Schlitt HJ, Dank M, Szasz AM, Herold Z. Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2024; 25(13):7495. https://doi.org/10.3390/ijms25137495

Chicago/Turabian Style

Panczel, Ivan, Miklos Acs, Magdolna Herold, Viktor Madar-Dank, Pompiliu Piso, Hans Jürgen Schlitt, Magdolna Dank, Attila Marcell Szasz, and Zoltan Herold. 2024. "Survival Difference of Endometrial Cancer Patients with Peritoneal Metastasis Receiving Cytoreductive Surgery (CRS) with and without Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Systematic Review and Meta-Analysis" International Journal of Molecular Sciences 25, no. 13: 7495. https://doi.org/10.3390/ijms25137495

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI